Cargando…

Fear, fight, familiarize: the experiences of people living with relapsing-remitting multiple sclerosis and taking oral medication

Purpose: In addition to becoming familiar with the life changing event of having a chronic illness and exploring its meaning in daily life, people with relapsing-remitting Multiple Sclerosis (RRMS) are faced with important decisions about immunomodulating treatment. Biomedical research on the use of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Reenen, Eva, Van Der Borg, Wieke, Visse, Merel, Van Der Meide, Hanneke, Visser, Leo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Empirical Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713094/ https://www.ncbi.nlm.nih.gov/pubmed/31390951 http://dx.doi.org/10.1080/17482631.2019.1648946

Ejemplares similares

Trapped in my lungs and fighting a losing battle. A phenomenological study of patients living with chronic obstructive and pulmonary disease
por: van der Meide, Hanneke, et al.
Publicado: (2019)

The Mindful Body: A Phenomenology of the Body With Multiple Sclerosis
por: van der Meide, Hanneke, et al.
Publicado: (2018)

Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis
por: van der Hiele, Karin, et al.
Publicado: (2015)

A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT’s) in multiple sclerosis (MS)
por: de Ceuninck van Capelle, Archibald, et al.
Publicado: (2017)

Development and Validation of Fear of Relapse Scale for Relapsing-Remitting Multiple Sclerosis: Understanding Stressors in Patients
por: Khatibi, Ali, et al.
Publicado: (2020)

The MS@Work study: a 3-year prospective observational study on factors involved with work participation in patients with relapsing-remitting Multiple Sclerosis
por: van der Hiele, Karin, et al.
Publicado: (2015)

Spiritual care by nurses in curative oncology: a mixed‐method study on patients’ perspectives and experiences
por: Ebenau, Anne, et al.
Publicado: (2019)

How to Start a Fight: A Qualitative Video Analysis of the Trajectories Toward Violence Based on Phone-Camera Recorded Fights
por: Weenink, Don, et al.
Publicado: (2022)

Can Schools Reduce Adolescent Psychological Stress? A Multilevel Meta-Analysis of the Effectiveness of School-Based Intervention Programs
por: van Loon, Amanda W. G., et al.
Publicado: (2020)

Cognitive functioning as a predictor of employment status in relapsing-remitting multiple sclerosis: a 2-year longitudinal study
por: van Gorp, Dennis A.M., et al.
Publicado: (2019)

Relapsing/remitting type 1 diabetes
por: van Megen, Kayleigh M., et al.
Publicado: (2017)

LINE-1 Hypermethylation in Serum Cell-Free DNA of Relapsing Remitting Multiple Sclerosis Patients
por: Dunaeva, Marina, et al.
Publicado: (2017)

Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?
por: Jongen, Peter Joseph, et al.
Publicado: (2015)

An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol
por: Jongen, Peter Joseph, et al.
Publicado: (2016)

Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study
por: van Pamelen, Jeske, et al.
Publicado: (2020)

Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study
por: Jongen, Peter Joseph, et al.
Publicado: (2014)

Developmental associations between risk‐taking and anxiety symptoms across ages 8–12 years
por: Tieskens, Jacintha M., et al.
Publicado: (2021)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis
por: Stühler, E., et al.
Publicado: (2020)

The incurable metastatic breast cancer experience through metaphors: the fight and the unveiling
por: Guité-Verret, Alexandra, et al.
Publicado: (2021)

Sports Participation and Juvenile Delinquency: A Meta-Analytic Review
por: Spruit, Anouk, et al.
Publicado: (2015)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
por: Findling, Oliver, et al.
Publicado: (2018)

The practice of dealing with existential questions in long-term elderly care
por: van der Vaart, Wander, et al.
Publicado: (2018)

Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
por: Bar-Or, Amit, et al.
Publicado: (2018)

Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later
por: Jongen, Peter Joseph, et al.
Publicado: (2016)

Toward a phenomenology of taking care
por: Coupé, Christophe, et al.
Publicado: (2022)

The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
por: Alroughani, Raed, et al.
Publicado: (2020)

Social Media and Body Dissatisfaction: Investigating the Attenuating Role of Positive Parent–Adolescent Relationships
por: de Vries, Dian A., et al.
Publicado: (2018)

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients
por: van Lierop, ZYGJ, et al.
Publicado: (2021)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)

Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis
por: Sotelo, Julio, et al.
Publicado: (2011)

Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: González-Andrade, Fabricio, et al.
Publicado: (2010)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Abnormal multisensory integration in relapsing–remitting multiple sclerosis
por: Giurgola, Serena, et al.
Publicado: (2022)

“It´s incredible how much I´ve had to fight.” Negotiating medical uncertainty in clinical encounters
por: Lian, Olaug S., et al.
Publicado: (2017)

Differentiating anxiety from fear: an experimental–pharmacological approach
por: Lippold, Julia V., et al.
Publicado: (2020)

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
por: Daruwalla, Cyrus, et al.
Publicado: (2023)

Changes of EEG band oscillations to tonic cold pain and the behavioral inhibition and fight-flight-freeze systems
por: De Pascalis, Vilfredo, et al.
Publicado: (2019)

Comparison of Pharmacological Therapies in Relapse Rates in Patients With Relapsing-Remitting Multiple Sclerosis
por: Etta, Indu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t6mob37q04jia0kmjm6vt9fl5e